Stock listing
gettex:CY71 Anixa Biosciences, Inc. Aktie
German listing (gettex) of Anixa Biosciences, Inc. · home listing NASDAQ:ANIX
Follow Anixa Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ANIX
$2.99 USD -0.13 (-4.2%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ANIX
- Day range
- $2.99 – $3.15 USDNov 2, 2026
- Volume
- 128,338 sharesNov 2, 2026
- Market cap
- $103.9M USDAt the close on Nov 2, 2026 · price × 34.76M shares outstanding
- 52-week range
- $2.32 – $5.46 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $841,857 USDMedian day 257,700 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ANIX · Home | $2.99 USD | -0.13 (-4.2%) | 128,338 | $3.14 | $3.151 | $2.99 | $3.12 | Close on Nov 2, 2026 |
| Frankfurt:CY71 | €2.895 EUR | +0.19 (+7.0%) | — | €2.905 | €2.905 | €2.895 | €2.705 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ANIX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.99 | -0.13 | -4.2% | $3.14 | $3.151 | $2.99 | 128,338 | |
| $3.12 | -0.18 | -5.5% | $3.28 | $3.35 | $3.10 | 140,407 | |
| $3.30 | -0.07 | -2.1% | $3.40 | $3.439 | $3.28 | 135,738 | |
| $3.37 | +0.09 | +2.7% | $3.26 | $3.43 | $3.20 | 251,324 | |
| $3.28 | +0.35 | +11.9% | $2.95 | $3.34 | $2.945 | 497,331 | |
| $2.93 | -0.06 | -2.0% | $2.94 | $2.98 | $2.90 | 135,562 | |
| $2.99 | +0.21 | +7.6% | $2.80 | $3.14 | $2.74 | 326,677 | |
| $2.78 | +0.07 | +2.6% | $2.70 | $2.78 | $2.68 | 154,000 | |
| $2.71 | +0.03 | +1.1% | $2.68 | $2.75 | $2.66 | 115,700 | |
| $2.68 | +0.07 | +2.7% | $2.64 | $2.75 | $2.64 | 163,100 | |
| $2.61 | -0.06 | -2.2% | $2.67 | $2.69 | $2.60 | 91,300 | |
| $2.67 | -0.11 | -4.0% | $2.79 | $2.82 | $2.65 | 123,400 | |
| $2.78 | +0.12 | +4.5% | $2.66 | $2.79 | $2.63 | 223,300 | |
| $2.66 | -0.01 | -0.4% | $2.75 | $2.82 | $2.63 | 228,400 | |
| $2.67 | -0.17 | -6.0% | $2.84 | $2.84 | $2.66 | 175,400 | |
| $2.84 | -0.06 | -2.1% | $2.90 | $2.92 | $2.83 | 97,700 | |
| $2.90 | -0.01 | -0.3% | $2.93 | $2.96 | $2.86 | 217,900 | |
| $2.91 | -0.04 | -1.4% | $2.93 | $2.93 | $2.86 | 259,600 | |
| $2.95 | -0.07 | -2.3% | $3.01 | $3.06 | $2.93 | 245,200 | |
| $3.02 | +0.07 | +2.4% | $2.95 | $3.11 | $2.87 | 344,900 | |
| $2.95 | 0.00 | 0.0% | $2.98 | $2.99 | $2.88 | 369,300 | |
| $2.95 | +0.18 | +6.5% | $2.83 | $2.95 | $2.77 | 433,300 | |
| $2.77 | -0.16 | -5.5% | $2.93 | $2.93 | $2.74 | 290,400 | |
| $2.93 | +0.08 | +2.8% | $2.85 | $2.95 | $2.81 | 428,900 | |
| $2.85 | +0.06 | +2.2% | $2.79 | $2.85 | $2.72 | 183,200 | |
| $2.79 | +0.01 | +0.4% | $2.78 | $2.83 | $2.70 | 305,500 | |
| $2.78 | 0.00 | 0.0% | $2.85 | $2.87 | $2.69 | 360,800 | |
| $2.78 | +0.03 | +1.1% | $2.74 | $2.81 | $2.72 | 257,700 | |
| $2.75 | -0.04 | -1.4% | $2.77 | $2.81 | $2.62 | 391,100 | |
| $2.79 | +0.09 | +3.3% | $2.73 | $2.79 | $2.68 | 434,100 | |
| $2.70 | -0.07 | -2.5% | $2.82 | $2.82 | $2.66 | 476,300 | |
| $2.77 | +0.01 | +0.4% | $2.78 | $2.79 | $2.69 | 315,200 | |
| $2.76 | +0.16 | +6.2% | $2.66 | $2.76 | $2.64 | 345,600 | |
| $2.60 | -0.09 | -3.3% | $2.70 | $2.72 | $2.56 | 557,400 | |
| $2.69 | -0.11 | -3.9% | $2.80 | $2.80 | $2.66 | 353,700 | |
| $2.80 | +0.04 | +1.4% | $2.79 | $2.88 | $2.76 | 376,400 | |
| $2.76 | +0.01 | +0.4% | $2.87 | $2.88 | $2.72 | 389,300 | |
| $2.75 | -0.08 | -2.8% | $2.76 | $2.81 | $2.66 | 400,100 | |
| $2.83 | -0.07 | -2.4% | $2.92 | $2.97 | $2.79 | 476,600 | |
| $2.90 | -0.17 | -5.5% | $3.10 | $3.20 | $2.88 | 441,200 | |
| $3.07 | +0.02 | +0.7% | $3.03 | $3.11 | $3.00 | 367,900 | |
| $3.05 | -0.08 | -2.6% | $3.14 | $3.25 | $2.99 | 409,100 | |
| $3.13 | -0.15 | -4.6% | $3.28 | $3.39 | $3.12 | 334,700 | |
| $3.28 | -0.07 | -2.1% | $3.41 | $3.49 | $3.23 | 342,200 | |
| $3.35 | -0.13 | -3.7% | $3.43 | $3.63 | $3.31 | 353,300 | |
| $3.48 | -0.12 | -3.3% | $3.60 | $3.67 | $3.42 | 214,700 | |
| $3.60 | -0.01 | -0.3% | $3.60 | $3.68 | $3.52 | 337,300 | |
| $3.61 | -0.05 | -1.4% | $3.64 | $3.75 | $3.47 | 291,300 | |
| $3.66 | +0.04 | +1.1% | $3.64 | $3.87 | $3.62 | 607,300 | |
| $3.62 | -0.09 | -2.4% | $3.66 | $3.73 | $3.51 | 138,800 | |
| $3.71 | +0.12 | +3.3% | $3.64 | $3.76 | $3.60 | 182,400 | |
| $3.59 | -0.12 | -3.2% | $3.69 | $3.71 | $3.55 | 168,500 | |
| $3.71 | +0.28 | +8.2% | $3.49 | $3.81 | $3.46 | 569,600 | |
| $3.43 | -0.06 | -1.7% | $3.41 | $3.49 | $3.33 | 117,800 | |
| $3.49 | +0.31 | +9.7% | $3.18 | $3.50 | $3.14 | 315,400 | |
| $3.18 | -0.02 | -0.6% | $3.20 | $3.23 | $3.10 | 107,800 | |
| $3.20 | -0.03 | -0.9% | $3.24 | $3.28 | $3.20 | 125,100 | |
| $3.23 | +0.01 | +0.3% | $3.21 | $3.34 | $3.20 | 145,300 | |
| $3.22 | -0.03 | -0.9% | $3.24 | $3.39 | $3.22 | 135,600 | |
| $3.25 | -0.17 | -5.0% | $3.32 | $3.40 | $3.22 | 257,700 | |
| $3.42 | -0.01 | -0.3% | $3.43 | $3.50 | $3.36 | 154,800 | |
| $3.43 | +0.02 | +0.6% | $3.41 | $3.53 | $3.36 | 106,500 | |
| $3.41 | 0.00 | 0.0% | $3.43 | $3.55 | $3.37 | 182,100 | |
| $3.41 | 0.00 | 0.0% | $3.42 | $3.55 | $3.38 | 194,800 | |
| $3.41 | -0.01 | -0.3% | $3.42 | $3.55 | $3.37 | 149,800 |
- Ticker
- gettex:CY71
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 26, 2026
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 24 slides
Latest news
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Oct 26, 2026
Closed $2.93 (-2.0%) on Oct 26, 2026
Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
Oct 13, 2026
Closed $2.67 (-6.0%) on Oct 13, 2026
Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
Oct 13, 2026
Closed $2.67 (-6.0%) on Oct 13, 2026
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
Oct 5, 2026
Closed $2.95 (0.0%) on Oct 5, 2026
Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
Oct 1, 2026
Closed $2.77 (-5.5%) on Oct 1, 2026
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
Sep 21, 2026
Closed $2.70 (-2.5%) on Sep 21, 2026
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
Sep 16, 2026
Closed $2.60 (-3.3%) on Sep 16, 2026
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
Sep 9, 2026
Closed $2.83 (-2.4%) on Sep 9, 2026
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
Sep 3, 2026
Closed $3.05 (-2.6%) on Sep 3, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 24 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 23 slides · September 2026
Investor Presentation (March 2026)
Investor deck · 21 slides · Mar 11, 2026
Shareholder Meeting (March 2025)
Shareholder meeting · 38 slides · Mar 21, 2025
Anixa Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 183 in all · newest Oct 26, 2026 · oldest 2019
- Decks
- 17 decks · latest October 2026
Where Anixa Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ANIX · Home listing | NASDAQ | United States | USD |
| gettex:CY71 · This page | gettex | Germany | EUR |
| LS Exchange:A2N6ZF | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2N6ZF | Lang & Schwarz | Germany | EUR |
| Frankfurt:CY71 | Frankfurt | Germany | EUR |
| Tradegate:CY71 | Tradegate | Germany | EUR |
| BOATS:ANIX | BOATS | United States | USD |
| Munich:CY71 | Munich | Germany | EUR |
| Dusseldorf:CY71 | Dusseldorf | Germany | EUR |
| Hamburg:CY71 | Hamburg | Germany | EUR |
| Stuttgart:CY71 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Anixa Biosciences, Inc.